Pancryos
  • ABOUT
    • COMPANY
    • TECHNOLOGY
    • TEAM
  • CONTACT
  • NEWS
Select Page

Biomarker May Allow for Type 1 Diabetes Stem Cell Therapy

Aug 9, 2017

Scientists in Denmark say they’re one step closer to developing a stem-cell therapy that could eventually allow patients with type 1 diabetes (T1D) to be insulin independent again. Read more here

  • Exclusive global license agreement for first in class macroencapsulation device
  • Innoboster grant
  • 300 Years of Leadership and Innovation
  • PanCryos “Ones to watch”
  • Licensing agreement with Takara Bio Europe AB